Cargando…

Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site

AIM: Previous studies have provided evidence that primary site surgery can improve the prognosis of rectal cancer patients, even in those with advanced age and distant metastasis, though results have been inconsistent. The current study aims to determine if all rectal cancer patients are likely to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jin, Yu, Wenqian, Xia, Jing, Li, Shiyi, Xie, Linshen, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259102/
https://www.ncbi.nlm.nih.gov/pubmed/37279737
http://dx.doi.org/10.1177/10732748231180056
_version_ 1785057596232695808
author Zhou, Jin
Yu, Wenqian
Xia, Jing
Li, Shiyi
Xie, Linshen
Wang, Xin
author_facet Zhou, Jin
Yu, Wenqian
Xia, Jing
Li, Shiyi
Xie, Linshen
Wang, Xin
author_sort Zhou, Jin
collection PubMed
description AIM: Previous studies have provided evidence that primary site surgery can improve the prognosis of rectal cancer patients, even in those with advanced age and distant metastasis, though results have been inconsistent. The current study aims to determine if all rectal cancer patients are likely to benefit from surgery in terms of overall survival. METHODS: This study examined the impact of primary site surgery on the prognosis of rectal cancer patients diagnosed between 2010 and 2019 using multivariable Cox regression analysis. The study also stratified patients by age group, M stage, chemotherapy, radiotherapy, and number of distant metastatic organs. The propensity score matching method was used to balance observed covariates between patients who received and did not receive surgery. The Kaplan–Meier method was used to analyze the data, and the log-rank test was used to determine differences between patients who did and did not undergo surgery. RESULTS: The study included 76,941 rectal cancer patients, with a median survival of 81.0 months (95% CI: 79.2–82.8 months). Of these patients, 52,360 (68.1%) received primary site surgery, and they tended to be younger, have higher differentiated grade, earlier T, N, M stage, and lower rates of bone, brain, lung, and liver metastasis, chemotherapy, and radiotherapy than those without surgery. Multivariable Cox regression analysis revealed that surgery had a protective effect on the prognosis of rectal cancer patients, including those with advanced age, distant metastasis, and multiple organ metastasis, but not in patients with four organ metastases. The results were also confirmed using propensity score matching. CONCLUSION: Not all rectal cancer patients could benefit from the surgery on the primary site, especially the patients with more than four distant metastases. The results could help the clinicians to tailor targeted treatment regimens and provide a guideline for making surgical decisions.
format Online
Article
Text
id pubmed-10259102
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102591022023-06-13 Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site Zhou, Jin Yu, Wenqian Xia, Jing Li, Shiyi Xie, Linshen Wang, Xin Cancer Control Original Research Article AIM: Previous studies have provided evidence that primary site surgery can improve the prognosis of rectal cancer patients, even in those with advanced age and distant metastasis, though results have been inconsistent. The current study aims to determine if all rectal cancer patients are likely to benefit from surgery in terms of overall survival. METHODS: This study examined the impact of primary site surgery on the prognosis of rectal cancer patients diagnosed between 2010 and 2019 using multivariable Cox regression analysis. The study also stratified patients by age group, M stage, chemotherapy, radiotherapy, and number of distant metastatic organs. The propensity score matching method was used to balance observed covariates between patients who received and did not receive surgery. The Kaplan–Meier method was used to analyze the data, and the log-rank test was used to determine differences between patients who did and did not undergo surgery. RESULTS: The study included 76,941 rectal cancer patients, with a median survival of 81.0 months (95% CI: 79.2–82.8 months). Of these patients, 52,360 (68.1%) received primary site surgery, and they tended to be younger, have higher differentiated grade, earlier T, N, M stage, and lower rates of bone, brain, lung, and liver metastasis, chemotherapy, and radiotherapy than those without surgery. Multivariable Cox regression analysis revealed that surgery had a protective effect on the prognosis of rectal cancer patients, including those with advanced age, distant metastasis, and multiple organ metastasis, but not in patients with four organ metastases. The results were also confirmed using propensity score matching. CONCLUSION: Not all rectal cancer patients could benefit from the surgery on the primary site, especially the patients with more than four distant metastases. The results could help the clinicians to tailor targeted treatment regimens and provide a guideline for making surgical decisions. SAGE Publications 2023-06-06 /pmc/articles/PMC10259102/ /pubmed/37279737 http://dx.doi.org/10.1177/10732748231180056 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Zhou, Jin
Yu, Wenqian
Xia, Jing
Li, Shiyi
Xie, Linshen
Wang, Xin
Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title_full Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title_fullStr Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title_full_unstemmed Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title_short Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site
title_sort not all rectal cancer patients could benefit from the surgery on the primary site
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259102/
https://www.ncbi.nlm.nih.gov/pubmed/37279737
http://dx.doi.org/10.1177/10732748231180056
work_keys_str_mv AT zhoujin notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite
AT yuwenqian notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite
AT xiajing notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite
AT lishiyi notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite
AT xielinshen notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite
AT wangxin notallrectalcancerpatientscouldbenefitfromthesurgeryontheprimarysite